GlassScriptPhysician profile
Gregory M Janda
NPI 1245473453
$12,161.97
in general payments reported to CMS, 2019-2025
17 companies · $944 in 2025
The $944 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,909 · 2020: $46.58 · 2021: $219 · 2022: $204 · 2023: $5,788 · 2024: $50.61 · 2025: $944.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $2,337 · Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $2,337.44 |
| Food and Beverage | $445.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,502.11 | 2019-2023 | Da Vinci Surgical System |
| Procept Biorobotics Corporation | $865.45 | 2025 | |
| 180 Medical, INC. | $178.24 | 2021-2024 | Gentlecath, Cure Catheter |
| Teleflex LLC | $107.54 | 2021 | |
| Palette Life Sciences, INC. | $77.05 | 2022 | |
| Abbvie INC. | $60.44 | 2023-2024 | |
| Astellas Pharma US INC | $54.49 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.71 | 2019-2023 | |
| Neotract INC. | $46.58 | 2020 | |
| Endo Pharmaceuticals INC. | $42.96 | 2021-2023 | Edex, Xiaflex, Aveed |
| C. R. Bard, INC. & Subsidiaries | $36.70 | 2025 | Aptra |
| Coloplast Corp | $36.46 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $36.10 | 2022-2023 | Trelstar |
| Hologic Sales and Service, LLC | $28.61 | 2025 | Coolseal Generator |
| Urogen Pharma, INC. | $24.08 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $13.53 | 2025 | |
| Travere Therapeutics, INC. | $1.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Janda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.